Supplementary Protection Certificate Search

Details

SPC number
SPC/GB04/002
Filing date
9 January 2004

Applicant(s) details

Name
AbbVie Biotechnology Ltd.
Address
Clarendon House
2 Church Street
Hamilton HM 11
Bermuda

Agent details

Name
Elkington and Fife LLP
Address
Prospect House
8 Pembroke Road
Sevenoaks
Kent TN13 1XR

Patent details

Patent number
EP0929578
Title
Human Antibodies that Bind Human TNFalpha

UK authorisation details

Authority date
1 September 2003
UK authorisations
  • EU/1/03/257/001
  • EU/1/03/257/002
  • EU/1/03/257/003
  • EU/1/03/257/004
  • EU/1/03/257/005
  • EU/1/03/257/006

Community authorisation details

Country
Switzerland
Dates and numbers
  • 16 April 2003 - 56'221

Product details

Product description
adalimumab
Status
Granted - 20 June 2005
Product type
Medicinal

Life details

In force date
10 February 2017
Actual expiry date
15 April 2018
Maximum expiry date
15 April 2018
Invalid date
Lapsed date
Lapsed status

Extension details

Lodged date
13 April 2015
Granted date
3 September 2015
Refused date
Revoked date
Expiry date
15 October 2018
Authorisation number
C(2015) 2249 final
Authorisation date
26 March 2015
Information concerning revocation actions and other legal proceedings on an SPC is included in the Patents Status Information record of the relevant patent.